A preliminary investigation on the efficacy of N-acetyl cysteine for mania or hypomania

N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action

(2014) Olivia Dean et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

The promise of N-acetylcysteine in neuropsychiatry

(2013) Michael Berk et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Translating the Rosetta Stone of N-Acetylcysteine

(2012) Olivia M. Dean et al.   BIOLOGICAL PSYCHIATRY

Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial

(2012) Michael Berk et al.   BMC Medicine

Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study

(2011) Pedro V. S. Magalhães et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: An open label trial

(2011) Michael Berk et al.   JOURNAL OF AFFECTIVE DISORDERS

N-acetyl cysteine restores brain glutathione loss in combined 2-cyclohexene-1-one and d-amphetamine-treated rats: Relevance to schizophrenia and bipolar disorder

(2011) Olivia M. Dean et al.   NEUROSCIENCE LETTERS

Mediators of allostasis and systemic toxicity in bipolar disorder

(2011) Iria Grande et al.   PHYSIOLOGY & BEHAVIOR

Systemic illness moderates the impact of N-acetyl cysteine in bipolar disorder

(2011) P.V. Magalhães et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

N-acetylcysteine for major depressive episodes in bipolar disorder

(2011) Pedro V Magalhães et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

New Therapeutic Targets for Mood Disorders

(2011) Rodrigo Machado-Vieira et al.   TheScientificWorldJOURNAL

Effects of N-acetyl-cysteine treatment on glutathione depletion and a short-term spatial memory deficit in 2-cyclohexene-1-one-treated rats

(2010) Kwok Ho Christopher Choy et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

N-acetyl cysteine add-on treatment for bipolar II disorder: a subgroup analysis of a randomized placebo-controlled trial

(2010) P.V. Magalhães et al.   JOURNAL OF AFFECTIVE DISORDERS

Peripheral biomarkers and illness activity in bipolar disorder

(2010) Flávio Kapczinski et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Pathways underlying neuroprogression in bipolar disorder: Focus on inflammation, oxidative stress and neurotrophic factors

(2010) M. Berk et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009

(2009) Lakshmi N Yatham et al.   BIPOLAR DISORDERS

A Role for Glutathione in the Pathophysiology of Bipolar Disorder and Schizophrenia? Animal Models and Relevance to Clinical Practice

(2009) O. Dean et al.   CURRENT MEDICINAL CHEMISTRY

A Double-Blind, Randomized, Placebo-Controlled 4-Week Study on the Efficacy and Safety of the Purinergic Agents Allopurinol and Dipyridamole Adjunctive to Lithium in Acute Bipolar Mania

(2009) Rodrigo Machado-Vieira et al.   JOURNAL OF CLINICAL PSYCHIATRY

N-Acetylcysteine reverses cocaine-induced metaplasticity

(2009) Khaled Moussawi et al.   NATURE NEUROSCIENCE

N-Acetyl Cysteine for Depressive Symptoms in Bipolar Disorder—A Double-Blind Randomized Placebo-Controlled Trial

(2008) Michael Berk et al.   BIOLOGICAL PSYCHIATRY

N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility

(2008) Seetal Dodd et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Oxidative stress in psychiatric disorders: evidence base and therapeutic implications

(2008) Felicity Ng et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Glutathione: a novel treatment target in psychiatry

(2008) Michael Berk et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The empirical redefinition of the psychometric criteria for remission in bipolar disorder

(2007) Michael Berk et al.   JOURNAL OF AFFECTIVE DISORDERS